2. Academic Validation
  3. Modulating tumor collagen fiber alignment for enhanced lung cancer immunotherapy via inhaled RNA

Modulating tumor collagen fiber alignment for enhanced lung cancer immunotherapy via inhaled RNA

  • Nat Commun. 2025 Aug 30;16(1):8120. doi: 10.1038/s41467-025-63415-0.
Bin Hu 1 2,  William Stewart 3,  Qijing Chen 1 2,  Chenshuang Zhang 1 2,  Zhixiang Liu 3,  Xiaoyang Xu 4 5,  Xue-Qing Zhang 6 7
Affiliations

Affiliations

  • 1 Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, China.
  • 2 National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai, China.
  • 3 Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, NJ, USA.
  • 4 Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, NJ, USA. xiaoyang.xu@njit.edu.
  • 5 Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, NJ, USA. xiaoyang.xu@njit.edu.
  • 6 Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, China. xueqingzhang@sjtu.edu.cn.
  • 7 National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai, China. xueqingzhang@sjtu.edu.cn.
PMID: 40885724 DOI: 10.1038/s41467-025-63415-0
Abstract

The clinical effectiveness of immunotherapies for lung cancers has been greatly hindered by the immune-excluded and immunosuppressive tumor microenvironment (TME) and limited pulmonary accessibility of therapeutics. Here, we develop an inhalable lipid nanoparticle (LNP) system that enables simultaneous delivery of mRNA encoding anti-discoidin domain receptor 1 (DDR1) single-chain variable fragments (mscFv) and siRNA targeting PD-L1 (siPD-L1) into pulmonary Cancer cells. The secreted anti-DDR1 scFv blocks the binding of DDR1 extracellular domain to Collagen, disrupting Collagen fiber alignment and reducing tumor stiffness, thereby facilitating T cell infiltration. Meanwhile, PD-L1 silencing alleviates immunosuppression and preserves T cell cytotoxicity. In vivo results demonstrate that mscFv@LNP induces Collagen fiber rearrangement and diminishes tumor stiffness. In both orthotopic and metastatic mouse models of lung Cancer, inhalation of mscFv/siPD-L1@LNP promotes tumor regression and extends overall survival. This strategy could be broadly applicable to solid tumors and benefit other Cancer immunotherapies by addressing the universally hostile TME involved in tumor progression.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z